The Washington Post addressed the mammogram recommendations by asking some questions to Kay Dickersin, director of the U.S. Cochrane Center and the Center for Clinical Trials at the John Hopkins Bloomberg School of Public Health (and a breast cancer survivor).
http://www.washingtonpost.com/wp-dyn...301801_pf.html